14-95117750-T-C
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BA1BP4
This summary comes from the ClinGen Evidence Repository: The NM_177438.3:c.1381A>G variant in DICER1 is a missense variant predicted to cause substitution of isoleucine by valine at amino acid 461 (p.Ile461Val). The highest population minor allele frequency in gnomAD v4.1.0 is 0.005261 (32/6082 alleles) in the Middle Eastern population, which is higher than the ClinGen DICER1 VCEP threshold (>0.003) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BA1. (Bayesian Points: NA; VCEP specifications version 1.3.0; 06/25/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA7331487/MONDO:0100216/024
Frequency
Consequence
NM_177438.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251200Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135770
GnomAD4 exome AF: 0.000163 AC: 238AN: 1461560Hom.: 1 Cov.: 31 AF XY: 0.000195 AC XY: 142AN XY: 727090
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74366
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 04, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Identified in a patient with pituitary macroadenoma (Martnez de LaPiscina et al., 2020); This variant is associated with the following publications: (PMID: 21266384, 34313605, 35384518, 32714280) - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 19, 2023 | - - |
DICER1-related tumor predisposition Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, reviewed by expert panel | curation | ClinGen DICER1 and miRNA-Processing Gene Variant Curation Expert Panel, ClinGen | Jun 25, 2024 | The NM_177438.3:c.1381A>G variant in DICER1 is a missense variant predicted to cause substitution of isoleucine by valine at amino acid 461 (p.Ile461Val). The highest population minor allele frequency in gnomAD v4.1.0 is 0.005261 (32/6082 alleles) in the Middle Eastern population, which is higher than the ClinGen DICER1 VCEP threshold (>0.003) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BA1. (Bayesian Points: NA; VCEP specifications version 1.3.0; 06/25/2024) - |
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Sep 17, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Malignant tumor of breast Benign:1
Benign, no assertion criteria provided | clinical testing | Center of Medical Genetics and Primary Health Care | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at